Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers

被引:36
作者
Chen, YX
Guo, YQ
Ge, XJ
Itoh, H
Watanabe, A
Fujiwara, T
Kodama, T
Aburatani, H
机构
[1] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Meguro Ku, Tokyo, Japan
[2] Univ Tokyo, Adv Sci & Technol Res Ctr, Div Mol Biol & Med, Meguro Ku, Tokyo, Japan
[3] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan
关键词
Sp5; transcription factors; human cancer; microarray; proliferation;
D O I
10.1016/j.bbrc.2005.12.068
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this report, we describe the expression and function of human Sp5, a member of the Sp family of zinc finger transcription factors. Like other family members, the Sp5 protein contains a Cys2His2 zinc finger DNA binding domain at the C-terminus. Our experiments employing Ga14-Sp5 fusion proteins reveal multiple transcriptional domains, including a N-terminal activity domain, an intrinsic repressive element, and a C-terminal synergistic domain. Elevated expression of Sp5 was noted in several human tumors including hepatocellular carcinoma, gastric cancer, and colon cancer. To study the effects of the Sp5 protein on growth properties of human cancer cells and facilitate the identification of its downstream genes, we combined an inducible gene expression system with microarray analysis to screen for its transcriptional targets. Transfer of Sp5 into MCF-7 cells that expressed no detectable endogenous Sp5 protein elicited significant growth promotion activity. Several of the constitutively deregulated genes have been associated with tumorigenesis (CDC25C, CEA-CAM6, TMPRSS2, XBP1, MYBL1, ABHD2, and CXCL12) and Wnt/beta-Catenin signaling pathways (BAMBI, SIX1, IGFBP5, AES, and p21(WAF1)). This information could be utilized for further mechanistic research and for devising optimized therapeutic strategies against human cancers. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:758 / 766
页数:9
相关论文
共 40 条
  • [1] Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells
    Abdelrahim, M
    Smith, R
    Burghardt, R
    Safe, S
    [J]. CANCER RESEARCH, 2004, 64 (18) : 6740 - 6749
  • [2] Regulation of the activity of Sp1-related transcription factors
    Bouwman, P
    Philipsen, S
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 195 (1-2) : 27 - 38
  • [3] All Tcf HMG box transcription factors interact with Groucho-related co-repressors
    Brantjes, H
    Roose, J
    van de Wetering, M
    Clevers, H
    [J]. NUCLEIC ACIDS RESEARCH, 2001, 29 (07) : 1410 - 1419
  • [4] Cell cycle development
    Coffman, JA
    [J]. DEVELOPMENTAL CELL, 2004, 6 (03) : 321 - 327
  • [5] ANALYSIS OF SP1 INVIVO REVEALS MULTIPLE TRANSCRIPTIONAL DOMAINS, INCLUDING A NOVEL GLUTAMINE-RICH ACTIVATION MOTIF
    COUREY, AJ
    TJIAN, R
    [J]. CELL, 1988, 55 (05) : 887 - 898
  • [6] P21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation
    Devgan, V
    Mammucari, C
    Millar, SE
    Brisken, C
    Dotto, GP
    [J]. GENES & DEVELOPMENT, 2005, 19 (12) : 1485 - 1495
  • [7] Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells
    Dong, LA
    Wang, WL
    Wang, F
    Stoner, M
    Reed, JC
    Harigai, M
    Samudio, I
    Kladde, MP
    Vyhlidal, C
    Safe, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) : 32099 - 32107
  • [8] Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1
    Facchinetti, V
    Lopa, R
    Spreafico, F
    Bolognese, F
    Mantovani, R
    Tavner, F
    Watson, R
    Introna, M
    Golay, J
    [J]. ONCOGENE, 2000, 19 (34) : 3931 - 3940
  • [9] Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas
    Fukumoto, S
    Yamauchi, N
    Moriguchi, H
    Hippo, Y
    Watanabe, A
    Shibahara, J
    Taniguchi, H
    Ishikawa, S
    Ito, H
    Yamamoto, S
    Iwanari, H
    Hironaka, M
    Ishikawa, Y
    Niki, T
    Sohara, Y
    Kodama, T
    Nishimura, M
    Fukayama, M
    Dosaka-Akita, H
    Aburatani, H
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (05) : 1776 - 1785
  • [10] Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3
    Gartel, AL
    Ye, X
    Goufman, E
    Shianov, P
    Hay, N
    Najmabadi, F
    Tyner, AL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) : 4510 - 4515